Objective: The goal of this study was to compare the end-tidal sevoflurane concentration and time for intravenous cannulation at induction of anesthesia using sevoflurane with or without nitrous oxide in healthy children and in those with developmental disabilities. Methods: Normal and developmentally disabled children were anesthetized by inhalation of sevoflurane with nitrous oxide or with nitrous oxide-free oxygen, and intravenous cannulae were introduced. The following parameters were recorded for each patient: age, sex, height, weight, BMI, duration of intravenous cannulation, intertidal concentration of sevoflurane at the completion of intravenous cannulation, and use of nitrous oxide. Two-way ANOVA was used for statistical evaluation of the experimental data. All values were expressed as mean ± standard deviation (SD) or number (n). p-values below 0.001 were considered statistically significant (two-way ANOVA). Results: In healthy children, the end-tidal sevoflurane concentrations at the completion of the intravenous cannulation showed a significant difference between when nitrous oxide was used (4.1 ± 0.8 %) and when nitrous oxide was not used (5.1 ± 1.1 %) (p<0.001). Also, in children with developmental disabilities, the end-tidal sevoflurane concentrations at intravenous cannulation showed a significant difference between when nitrous oxide was used (4.2 ± 0.9 %) and when nitrous oxide was not used (4.9 ± 1.3 %) (p<0.001). However, there was no significant difference in the time required for intravenous cannulation from the start of anesthesia induction in either group. Conclusions:Between the healthy children and the children with developmental disabilities, no significant differences in the end-tidal sevoflurane concentrations at the completion of the intravenous cannulation and the time for the intravenous cannulation from the beginning of anesthetic induction.
Objective The goal of this study was to compare the end-tidal sevoflurane concentration and time for intravenous cannulation at induction of anesthesia using sevoflurane with or without nitrous oxide in healthy children and in those with developmental disabilities. Methods Normal and developmentally disabled children were anesthetized by inhalation of sevoflurane with nitrous oxide or with nitrous oxide-free oxygen, and intravenous cannulae were introduced. Nitrous oxide was stopped after loss of consciousness. The following parameters were recorded for each patient: age, gender, height, weight, BMI, duration of intravenous cannulation, end-tidal concentration of sevoflurane at the completion of intravenous cannulation, and use of nitrous oxide. For each parameter except gender, p-value were calculated by one-way analysis of variance (ANOVA). For gender, p-value were calculated using the Fisher method. Two-way ANOVA was performed to evaluate the effect of patient health status and nitrous oxide use on the end-tidal concentrations of sevoflurane and the time required for intravenous cannulation. Results The end-tidal sevoflurane concentrations at the completion of the intravenous cannulation had received a significant main effect of the factor "the use of nitrous oxide" (F(1,166) = 25.8, p < 0.001, η2 = 0.13) and a small effect of the factor "the patient health status" (F(1,166) = 0.259, p = 0.611, η2 = 0.001). However, the time required for intravenous cannulation was not significantly affected by either of the two factors, "the use of nitrous oxide" (F(1,166) = 0.454, p = 0.501, η2 = 0.003) and "the patient health status" (F(1,166) = 0.308, p = 0.579, η2 = 0.002). Conclusions Between the healthy children and the children with developmental disabilities, no significant differences in the time required for the intravenous cannulation from the beginning of anesthetic induction. However, the end-tidal sevoflurane concentrations at the completion of the intravenous cannulation was significantly different. Sevoflurane in alveoli might be diluted by nitrous oxide.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.